Expression of MHC class I heavy chain and β2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons

Journal of Neuroimmunology

Volumn 101, Issue 1, 1999, Pages 76-86

  Lindå, Hans ^a,b   Hammarberg, Henrik ^b   Piehl, Fredrik ^a,b   Khademi, Mohsen ^a   Olsson, Tomas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

2 Microglobulin; Brainstem motoneurons; Dopaminergic neurons; Interferon gamma receptor; MHC class I

Indexed keywords

BETA 2 MICROGLOBULIN; GAMMA INTERFERON RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BRAIN STEM; DOPAMINERGIC NERVE CELL; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOTONEURON; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BETA 2-MICROGLOBULIN; BRAIN STEM; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOTOR NEURONS; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERFERON; RNA, MESSENGER; SUBSTANTIA NIGRA;

EID: 0032720859     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00135-6     Document Type: Article

References (41)

1. Agid, Y., Javoy-Agid, F., Ruberg, M., 1987. Biochemistry of neurotransmitters in Parkinson's disease. In: Marsden, Fahn (Eds.), Movement Disorders, Vol. 2. Butterworth, London, p. 166.
2. b. Proc. Natl. Acad. Sci. U.S.A. 83:1986;7447-7451.
3. Altschul S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST; a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
4. Appel S.H., Smith R.G., Engelhardt J.I., Stefani E. Evidence for autoimmunity in amyotrophic lateral sclerosis. J. Neurol. Sci. 118:1993;169-174.
5. Arsac C., Raymond C., Martin-Moutot N., Dargent B., Couraud F., Pouget J., Saeger M. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum. Ann. Neurol. 40:1996;695-700.
6. Babbitt B.P., Allen P.M., Matsueda G., Haber E., Unanue E.R. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature. 317:1985;359-361.
7. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 329:1987;506-512.
8. Braud V.M., Allan D.S.J., O'Callaghan C.A., Soderstrom K., Dandrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795-799.
9. Colom L.V., Alexianu M.E., Mosier D.R., Smith R.G., Appel S.H. Amyotrophic lateral sclerosis immunoglobulins increase intracellular calcium in a motoneuron cell line. Exp. Neurol. 146:1997;354-360.
10. Corriveau R.A., Huh G.S., Shatz C.J. Regulation of class I MHC gene expression in the developing and mature CNS by neuronal activity. Neuron. 21(3):1998;505-520.
11. Dagerlind Å., Friberg K., Bean A.J., Hökfelt T. Sensitive mRNA detection using unfixed tissue; combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry. 98:1992;39-49.
12. Fiszer U., Mix E., Fredrikson S., Kostulas V., Olsson T., Link H. Gamma-delta+T-cells are increased in patients with Parkinson's disease. J. Neurol. Sci. 121:1994;39-45.
13. Glas R., Franksson L., Öhlen C., Höglund P., Koller B., Ljunggren H., Kärre K. Major histocompatibility complex class I-specific and restricted killing of β2-microglobulin-deficient cells by CD8+ cytotoxic T-lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 89:1992;11381-11385.
14. Hyman R., Stallings V. Characterization of a TL-variant of a homozygous TL+ mouse lymphoma. Immunogenetics. 3:1976;75-84.
15. Hyman R., Throwbridge I. Analysis of lymphocyte surface antigen expression by the use of variant cell lines. Cold Spring Harbor Symp. Quant. Biol. 407:1977;. Pt. 1.
16. Joly E., Mucke L., Oldstone M.B.A. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 253:1991;1283-1285.
17. Kostic V., Gurney M.E., Deng H.X., Siddique T., Epstein C.J., Przedborski S. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann. Neurol. 41:1997;497-504.
18. Krangel M.S., Orr H.T., Strominger J.L. Assembly and maturation of HLA-A and HLA-B antigens in vivo. Cell. 18:1979;979-991.
19. Lampson L.A., Hickey W.F. Monoclonal antibody analysis of MHC expression in human brain biopsies; tissue ranging from histologically normal to that showing different levels of glial tumor involvement. J. Immunol. 136:1986;4054-4062.
20. Lampson L.A., Kushner P.D., Sobel R.A. Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis. Ann. Neurol. 28:1990;365-372.
21. Leong L.Y.W., Le Rolle A.F., Deverson E., Powis S.J., Larkins A.P., Vaage J.T., Stockland A., Lambracht-Washington D., Rolstad B., Joly E., Butcher G.W. RT1-U: identification of a novel, active, class Ib alloantigen of the rat MHC. J. Immunol. 162:1999;743-752.
22. Lindå H., Hammarberg H., Cullheim S., Levinovitz A., Khademi M., Olsson T. Expression of MHC class I and β2-microglobulin in rat spinal motoneurons; regulatory influences by IFN-gamma and axotomy. Exp. Neurol. 150:1998;282-295.
23. Ljungdahl Å., Olsson T., van der Meide P.H., Holmdahl R., Klareskog L., Höjeberg B. Interferon-gamma-like immunoreactivity in certain neurons of the central and peripheral nervous system. J. Neurosci. Res. 24:1989;451-456.
24. Maehlen J., Nennesmo I., Olsson A.-B., Olsson T., Schröder H.D., Kristensson K. Peripheral nerve injury causes transient expression of MHC class I antigens in rat motor neurons and skeletal muscles. Brain Res. 481:1989;368-372.
25. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 38:1988;1285-1291.
26. Mucke L., Oldstone M.B.A. The expression of major histocompatibility complex (MHC) class 1 antigens in the brain differs markedly in acute and persistent infections with lymphocytic choriomeningitis virus (LCMV). J. Neuroimmunol. 36:1992;193-198.
27. Neumann H., Cavalié A., Jenne D.E., Wekerle H. Induction of MHC class 1 genes in neurons. Science. 269:1995;549-551.
28. Nyormoi O. Proteolytic activity in amyotrophic lateral sclerosis IgG preparations. Ann. Neurol. 40:1996;701-706.
29. Offen D., Halevi M.A., Orion D., Mosberg R., Stern-Goldberg H., Melamed E., Atlas D. Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels. Neurology. 51:1998;1100-1103.
30. Olsson T., Kristensson K., Ljungdahl Å., Maehlen J., Holmdahl R., Klareskog L. Gamma-interferon-like immunoreactivity in axotomized rat motor neurons. J. Neurosci. 9:1989;3870-3875.
31. Parnes J.R. Molecular biology and function of CD4 and CD8. Adv. Immunol. 44:1989;265-311.
32. Piehl F., Ru-Rong J., Cullheim S., Hökfelt T., Lindholm D., Hughes R.A. Fibroblast growth factors regulate calcitonin-gene-related peptide mRNA expression in rat motoneurons after lesion and in culture. Eur. J. Neurosci. 7:1995;1739-1750.
33. Pouplard A., Emile J., Pouplard F., Hurez D. Parkinsonism and autoimmunity; antibody against human sympathetic ganglion cells in Parkinson's disease. Adv. Neurol. 24:1979;321-326.
34. Rivera-Quinones C., McGavern D., Schmelzer J.D., Hunter S.F., Low P.A., Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 4(2):1998;187-193.
35. Silver M.L., Parker K.C., Wiley D.C. Reconstitution by MHC-restricted peptides of HLA-A2 heavy chain with beta 2-microglobulin. Nature. 350:1991;619-622.
36. Stagsted J., Reaven G.M., Hansen T., Goldstein A., Olsson L. Regulation of Insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen. Cell. 62:1990;297-307.
37. Takahashi H., Snow B.J., Bhatt M.H., Peppard R., Eisen A., Calne D.B. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet. 342:1993;1016-1018.
38. Tu P.H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., Lee V.M. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. PNAS. 93:1996;3155-3160.
39. Turnley A.M., Morahan G., Okano H., Bernard O., Mikoshiba K., Allison J., Bartlett P.F., Miller J.F.A.P. Dysmyelination in transgenic mice resulting from expression of class I histocompability molecules in oligodendrocytes. Nature. 353:1991;566-569.
40. Vass K., Lassman H. Intrathecal application of interferon gamma. Am. J. Pathol. 137:1990;789-800.
41. Yamada T., Akiyama M., McGeer P.L. Complement-activated oligodendroglia; a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d. Neurosci. Lett. 112:1990;161-166.